The pharmaceutical company “Darnitsa” has presented a series of drugs to combat pain and inflammation in adults and children. According to the International Association for the Study of Pain (IASP), pain is one of the most frequent reasons why patients go to see a doctor. Dmytro Shymkiv, the chairman of the Darnitsa Group Board of Directors, mentioned this in his interview.
According to him, if there is no proper treatment, pain can significantly worsen the quality of life of the patient, but also of their family, as well as cause negative consequences for society in general. If there are comorbid conditions such as depression and anxiety, they can exacerbate the pain and intensify its severity. Pain reduces performance, it can lead to social isolation and limit the working capacity of a person for a long time.
Darfen is an effective medicine to relieve pain and improve the quality of life of patients. The wide range of the brand and the range of dosage forms allow customers to choose the optimal solution for treatment of patients of different ages and with different indications. Currently, there are four drugs presented under the Darfen brand: the local analgesic Darfen Gel and oral forms in the form of a gel, tablets and suspensions – Darfen Long, Darfen Kids and Darfen Kids Forte. Medicines are recommended for the symptomatic treatment of mild to moderate pain in migraines, headaches, back pain, menstrual pain, toothache, rheumatic and muscle pain, sports injuries, pain in mild arthritis, symptoms of colds and flu, sore throat and fever.
Dmytro Shymkiv, the top manager, answering a question about the development strategy of the concern, said that within 6 months of this year the pharmaceutical company “Darnitsa” has brought to the market 12 new brands of drugs for treating diseases of nervous and cardiovascular systems and pain management. Now the company’s portfolio includes 210 brands of medicines, and by the end of 2021 it is planned to expand it with 25 new drugs.
The products of “Darnitsa” are exported to 15 countries of the world. The company was founded in 1930 and since 1998 has been the leader in Ukraine in terms of the volume of production of drugs in physical terms. The top manager also highlighted that the company’s mission is to help medical workers and patients improve the quality of life through science, innovation and accessibility.